Abstract Background Peptide receptor radionuclide therapy (PRRT) with [177Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Absorbed doses are calculated from the radioactivity in the blood and from single photon emission computed tomography (SPECT) images corrected by computed tomography (CT) acquired after each course of treatment. The aim of this work is to assess whether the dosimetry along all treatment cycles can be calculated using a single CT. We hypothesize that the absorbed doses to the risk organs calculated with a single CT will be accurate enough to c...
Radiation dose to the kidneys (kidney dose) in 177Lu-DOTATATE - Peptide Receptor Radionuclide Therap...
International audienceBACKGROUND: This study's aim was to develop our dosimetric methodology using a...
Peptide-receptor-radionuclide-therapy (PPRT) is a targeted therapy that combines a short-range energ...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Abstract Background Recently, 177Lu-dotatate therapy for neuroendocrine tumours has received regulat...
Abstract Background Following each cycle of peptide receptor radionuclide therapy (PRRT), absorbed d...
Targeted radionuclide therapy has been shown to be one of the most effective treatment options for m...
International audienceBackground: The number of SPECT/CT time-points is important for accurate patie...
Introduction: In Peptide Receptor Radionuclide Therapy (PRRT), the administration of radionuclide su...
Purpose: Peptide receptor radionuclide therapy with 177Lu-DOTATATE has become a standard treatment m...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Abstract Background The main challenge for systemic radiation therapy using radiopharmaceuticals (SR...
International audienceBackground: The number of SPECT/CT time-points is important for accurate patie...
Peptide receptor radionuclide therapy (PRRT) shows promising results in the treatment of neuroendoc...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Radiation dose to the kidneys (kidney dose) in 177Lu-DOTATATE - Peptide Receptor Radionuclide Therap...
International audienceBACKGROUND: This study's aim was to develop our dosimetric methodology using a...
Peptide-receptor-radionuclide-therapy (PPRT) is a targeted therapy that combines a short-range energ...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Abstract Background Recently, 177Lu-dotatate therapy for neuroendocrine tumours has received regulat...
Abstract Background Following each cycle of peptide receptor radionuclide therapy (PRRT), absorbed d...
Targeted radionuclide therapy has been shown to be one of the most effective treatment options for m...
International audienceBackground: The number of SPECT/CT time-points is important for accurate patie...
Introduction: In Peptide Receptor Radionuclide Therapy (PRRT), the administration of radionuclide su...
Purpose: Peptide receptor radionuclide therapy with 177Lu-DOTATATE has become a standard treatment m...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Abstract Background The main challenge for systemic radiation therapy using radiopharmaceuticals (SR...
International audienceBackground: The number of SPECT/CT time-points is important for accurate patie...
Peptide receptor radionuclide therapy (PRRT) shows promising results in the treatment of neuroendoc...
In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), i...
Radiation dose to the kidneys (kidney dose) in 177Lu-DOTATATE - Peptide Receptor Radionuclide Therap...
International audienceBACKGROUND: This study's aim was to develop our dosimetric methodology using a...
Peptide-receptor-radionuclide-therapy (PPRT) is a targeted therapy that combines a short-range energ...